Instil Bio (TIL)
(Delayed Data from NSDQ)
$26.99 USD
+2.25 (9.09%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $27.07 +0.08 (0.30%) 6:18 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TIL 26.99 +2.25(9.09%)
Will TIL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TIL
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
TIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice
Summit Therapeutics Stock Nosedives on Mixed NSCLC Study Results
Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
Other News for TIL
Instil Bio (TIL) Gains from Promising Clinical Trial Results
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying ...
Instil Bio to begin testing antibody therapy in solid tumors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session